BREAKING: FDA authorizes Pfizer Covid booster for emergency use in American ages 65 and over, as well as those at high risk of exposure to the coronavirus or severe illness, according to a senior administration official.
a third dose of the Pfizer-BioNTech Covid-19 vaccine on Wednesday for emergency use in people ages 65 and up, as well as those at high risk of exposure to the coronavirus or severe illness. Boosters are to be given six months after a person receives their second dose of the Pfizer vaccine.
However, the timing of the FDA decision cast an air of uncertainty over the first day of the ACIP meeting, which usually knows at the outset what FDA decision it will be considering. Instead, the FDA announcement did not come until after the meeting concluded for the day Wednesday.Pfizer originally asked the FDA to consider a third dose for everyone ages 16 and older six months after they received their second dose.
In rejecting Pfizer's original request — that a booster be made available to everyone ages 16 and older — the FDA committee cited concerns about the shot's possible side effects, such asACIP members also struck a skeptical tone for much of Wednesday’s discussions on booster doses.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
The FDA Could Soon Review the Pfizer Vaccine for Children Ages 5 to 11If all goes as planned, millions of children could be vaccinated by Halloween.
Weiterlesen »
Pfizer says its vaccine works in kids aged 5 to 11 – latest updatesPfizer shot works in kids aged 5 to 11. Other Covid updates: ⚰️ More Americans killed by Covid than 1918 flu ✈️ India to resume global vaccine exports in Oct 💉 Vietnam to buy 10M jabs from Cuba More here:
Weiterlesen »
U.S. To Donate 500 Million More Pfizer Vaccine Doses To Poorer CountriesI am a London-based reporter for Forbes covering breaking news. Previously, I have worked as a reporter for a specialist legal publication covering big data and as a freelance journalist and policy analyst covering science, tech and health. I have a master’s degree in Biological Natural Sciences and a master’s degree in the History and Philosophy of Science from the University of Cambridge. Follow me on Twitter theroberthart or email me at rhartforbes.com
Weiterlesen »
Pfizer Study of Covid-19 Vaccine in Pregnant Women Delayed by Slow EnrollmentPfizer wanted to study its Covid-19 vaccine in pregnant women, but then the shots became widely available; “It’s hard to enthusiastically recommend the study when you’ve got a vaccine out there,” says one doctor
Weiterlesen »
U.S. CDC advisers could vote on Pfizer COVID-19 vaccine booster on ThursdayThe CDC's Advisory Committee on Immunization Practices (ACIP) is meeting on Sept 22-23 to discuss which Americans should get the third vaccine shot, should it be authorized for use by the Food and Drug Administration. Pfizer has asked the FDA to approve the third shot for all people aged 16 and over, but a panel of outside advisors to the FDA last Friday said there was only evidence for a shot being needed by people aged 65 and older.
Weiterlesen »
Pfizer Vaccine Could Be Available For Kids Ages 5-11 By HalloweenPfizer Vaccine Could Be Available For Kids Ages 5-11 By Halloween “Former FDA commissioner Dr. Scott Gottlieb says, ‘I think that there's a possibility you could have a vaccine as early as around Halloween.’” 👏👏👏
Weiterlesen »